跳至主要内容
临床试验/NCT02460354
NCT02460354终止1 期

Use of Metformin to Treat Patients With Congenital Nephrogenic Diabetes Insipidus (NDI)

Emory University3 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2015年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
2
试验地点
3
主要终点
Change in mean urine osmolality

研究概览

简要总结

The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (NDI).

详细描述

Nephrogenic diabetes insipidus (NDI) is a genetic disease. Patients with this disease make large amounts of urine because their kidneys don't hold on to water. The large amount of urine means that patients need to urinate very frequently. They are also at increased risk for dehydration if they don't drink enough. The large amount of urine can sometimes damage their bladders and kidneys. There are some medicines that may help these patients urinate less, but they are not very effective. There is evidence in animal studies that a medication called metformin may help patients with NDI urinate less.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Males with a documented mutation in the vasopressin type 2 receptor (V2R)
  • Willing to provide consent and/or assent as appropriate
  • Capable of providing urine samples as dictated by the protocol

排除标准

  • Urinary incontinence
  • Subjects who have heart disease, liver disease, diabetes, cancer, or other significant disease other than Nephrogenic Diabetes Insipidus (NDI)
  • Subjects with significant renal dysfunction (defined as a calculated glomerular filtration rate (GFR) <80 ml/min/1.73 m^2)
  • Subjects with acquired NDI

研究组 & 干预措施

Metformin

Experimental

Subjects with congenital nephrogenic diabetes insipidus (NDI) will receive one metformin 500 mg pill orally

干预措施: Metformin (Drug)

结局指标

主要结局

Change in mean urine osmolality

时间窗: Baseline, 7 hours

Urine osmolality is a measure of urine concentration. Urine osmolality will be measured using a Wescor vapor pressure osmometer. A normal range for urine osmolality is approximately 500-850 mOsm/kg water. Change is the difference in average osmolality from baseline to 7 hours.

次要结局

  • Change in mean urine volume(Baseline, 7 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Larry Greenbaum, MD, PhD

Professor

Emory University

研究点 (3)

Loading locations...

相似试验